161 related articles for article (PubMed ID: 27054116)
21. A relative quantitative method to detect OCT4A gene expression by exon-junction primer and locked nucleic acid-modified probe.
Ren JJ; Meng XK
J Zhejiang Univ Sci B; 2011 Feb; 12(2):149-55. PubMed ID: 21265047
[TBL] [Abstract][Full Text] [Related]
22. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
[TBL] [Abstract][Full Text] [Related]
23. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene.
Lin H; Shabbir A; Molnar M; Lee T
Biochem Biophys Res Commun; 2007 Mar; 355(1):111-6. PubMed ID: 17280643
[TBL] [Abstract][Full Text] [Related]
24. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.
Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J
J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710
[TBL] [Abstract][Full Text] [Related]
25. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
27. The novel function of OCT4B isoform-265 in genotoxic stress.
Gao Y; Wei J; Han J; Wang X; Su G; Zhao Y; Chen B; Xiao Z; Cao J; Dai J
Stem Cells; 2012 Apr; 30(4):665-72. PubMed ID: 22247013
[TBL] [Abstract][Full Text] [Related]
28. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
29. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
[TBL] [Abstract][Full Text] [Related]
30. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.
Atlasi Y; Mowla SJ; Ziaee SA; Gokhale PJ; Andrews PW
Stem Cells; 2008 Dec; 26(12):3068-74. PubMed ID: 18787205
[TBL] [Abstract][Full Text] [Related]
31. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
32. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
Wang L; Guo ZY; Zhang R; Xin B; Chen R; Zhao J; Wang T; Wen WH; Jia LT; Yao LB; Yang AG
Carcinogenesis; 2013 Aug; 34(8):1773-81. PubMed ID: 23615404
[TBL] [Abstract][Full Text] [Related]
33. Revisiting OCT4 expression in peripheral blood mononuclear cells.
Kotoula V; Papamichos SI; Lambropoulos AF
Stem Cells; 2008 Jan; 26(1):290-1. PubMed ID: 17932416
[TBL] [Abstract][Full Text] [Related]
34. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
35. Differential Expression Pattern of linc-ROR Spliced Variants in Pluripotent and Non-Pluripotent Cell Lines.
Mirzadeh Azad F; Taheri Bajgan E; Naeli P; Rudov A; Bagheri Moghadam M; Sadat Akhtar M; Gholipour A; Mowla SJ; Malakootian M
Cell J; 2022 Oct; 24(10):569-576. PubMed ID: 36259474
[TBL] [Abstract][Full Text] [Related]
36. OCT4 pseudogenes present in human leukemia cells.
Guo X; Tang Y
Clin Exp Med; 2012 Dec; 12(4):207-16. PubMed ID: 22086193
[TBL] [Abstract][Full Text] [Related]
37. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response.
Wang X; Zhao Y; Xiao Z; Chen B; Wei Z; Wang B; Zhang J; Han J; Gao Y; Li L; Zhao H; Zhao W; Lin H; Dai J
Stem Cells; 2009 Jun; 27(6):1265-75. PubMed ID: 19489092
[TBL] [Abstract][Full Text] [Related]
38. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Carrett-Dias M; Dos Santos Machado K; Werhli A; Cañedo AD; Trindade GS; de Souza Votto AP
Mol Biol Rep; 2019 Apr; 46(2):1873-1884. PubMed ID: 30721421
[TBL] [Abstract][Full Text] [Related]
39. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
Sotomayor P; Godoy A; Smith GJ; Huss WJ
Prostate; 2009 Mar; 69(4):401-10. PubMed ID: 19058139
[TBL] [Abstract][Full Text] [Related]
40. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
